Nebulised ipratropium combined with albuterol led to improved pulmonary function in children with severe asthma

doi:10.1136/ebm.1998.3.103

August 1, 1998Evidence-Based Medicine

Nebulised ipratropium combined with albuterol led to improved pulmonary function in children with severe asthma

View at Publisher

Ask AI

Bookmark

Share

Key Points

Combined therapy significantly improved pulmonary function in children with severe asthma, enhancing overall management.
Key findings indicate positive results from the combination of nebulised ipratropium and albuterol for pulmonary function.
The approach involved comparing treatment outcomes in children and highlights the effectiveness of this combination therapy.
The findings support the need for considering combined nebulised treatments in managing severe asthma in pediatric patients.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Observation reveals improved pulmonary function in children with severe asthma, suggesting nebulised therapies may enhance treatment outcomes.

Abstract

To the Editor : Is there a misprint at the end of the authors' response to the commentary by Silverman (1)? The conclusion of the quoted paper is positive: Combining ipratropium with albuterol is beneficial.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

A 1998 study studied this question.

synapsesocial.com/papers/68b033590a36ac2c8db3cd10 https://doi.org/10.1136/ebm.1998.3.103

View at Publisher

Ask AI

Bookmark

Share

Nebulised ipratropium combined with albuterol led to improved pulmonary function in children with severe asthma

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Nebulised ipratropium combined with albuterol led to improved pulmonary function in children with severe asthma

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading